The current way to measure PDL-1 biomarkers will not stand the test of time
Second vote and conclusions
Date
08 Oct 2016Session
The current way to measure PDL-1 biomarkers will not stand the test of timePresenters
Thomas PowlesAuthors
T. PowlesAuthor affiliations
- Oncology, 07836 - Albany/US
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
Introduction and first vote
Presenter: Thomas Powles
Session: The current way to measure PDL-1 biomarkers will not stand the test of time
Resources:
Slides
Webcast
Yes
Presenter: Naiyer Rizvi
Session: The current way to measure PDL-1 biomarkers will not stand the test of time
Resources:
Slides
Webcast
No
Presenter: Keith Kerr
Session: The current way to measure PDL-1 biomarkers will not stand the test of time
Resources:
Slides
Webcast